SELLAS Life Sciences Group Inc.(SLS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

SLS SELLAS Life Sciences Group Inc.

Pre-Mkt 08-06 07:19:17 EDT

11.86

+0.05

+0.42%

盘前11.83

-0.03-0.24%

07:18 EDT

High12.06	Low11.39	Vol5.76M
Open11.80	D1 Closing11.81	Amplitude5.67%
Mkt Cap2.34B	Tradable Cap2.32B	Total Shares197.00M
T/O67.79M	T/O Rate2.94%	Tradable Shares196.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"SLS","market":"US","secType":"STK","nameCN":"SELLAS Life Sciences Group Inc.","latestPrice":11.86,"timestamp":1785960000000,"preClose":11.81,"halted":0,"volume":5763576,"hourTrading":{"tag":"盘前","latestPrice":11.8313,"preClose":11.86,"latestTime":"07:18 EDT","volume":8345,"amount":99123.804315,"timestamp":1786015119801,"change":-0.0287,"changeRate":-0.00242,"amplitude":0.01855},"delay":0,"changeRate":0.004233700254021925,"floatShares":196000000,"shares":197000000,"eps":-0.226189,"marketStatus":"Pre-Mkt","change":0.05,"latestTime":"08-06 07:19:17 EDT","open":11.8,"high":12.06,"low":11.39,"amount":67787313.552504,"amplitude":0.056732,"askPrice":11.96,"askSize":1600,"bidPrice":11.8,"bidSize":60,"shortable":3,"etf":0,"ttmEps":-0.226189,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1786023000000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":11.86,"preHourTrading":{"tag":"盘前","latestPrice":11.8313,"preClose":11.86,"latestTime":"07:18 EDT","volume":8345,"amount":99123.804315,"timestamp":1786015119801,"change":-0.0287,"changeRate":-0.00242,"amplitude":0.01855},"postHourTrading":{"tag":"盘后","latestPrice":12,"preClose":11.86,"latestTime":"19:59 EDT","volume":158715,"amount":1894271.2136,"timestamp":1785974399556,"change":0.14,"changeRate":0.011804,"amplitude":0.024452},"volumeRatio":1.0708312104253137,"impliedVol":2.3766,"impliedVolPercentile":0.848},"requestUrl":"/m/hq/s/SLS/wiki","defaultTab":"wiki","newsList":[{"id":"2656588698","title":"Canaccord Genuity Keeps Their Buy Rating on Solstice Minerals Limited (SLS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2656588698","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656588698?lang=en_us&edition=fundamental","pubTime":"2026-08-04 07:35","pubTimestamp":1785800121,"startTime":"0","endTime":"0","summary":"In a report released today, Paul Howard CFA from Canaccord Genuity maintained a Buy rating on Solstice Minerals Limited, with a price target of A$2...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/canaccord-genuity-keeps-their-buy-rating-on-solstice-minerals-limited-sls-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/canaccord-genuity-keeps-their-buy-rating-on-solstice-minerals-limited-sls-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656081543","title":"Moderately bullish activity in Sellas Life Sciences with shares up 7.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2656081543","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656081543?lang=en_us&edition=fundamental","pubTime":"2026-08-03 23:55","pubTimestamp":1785772517,"startTime":"0","endTime":"0","summary":"Moderately bullish activity in Sellas Life Sciences (SLS), with shares up 74c, or 7.39%, near $10.75. Options volume roughly in line with average w...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/moderately-bullish-activity-in-sellas-life-sciences-with-shares-up-7-39-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/moderately-bullish-activity-in-sellas-life-sciences-with-shares-up-7-39-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SLS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656396158","title":"Cboe data shows mixed options sentiment in Sellas Life Sciences with shares down 3.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2656396158","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656396158?lang=en_us&edition=fundamental","pubTime":"2026-08-01 03:40","pubTimestamp":1785526822,"startTime":"0","endTime":"0","summary":"Cboe data shows mixed options sentiment in Sellas Life Sciences (SLS), with shares down 34c near $9.95. Options volume relatively light with 25k co...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cboe-data-shows-mixed-options-sentiment-in-sellas-life-sciences-with-shares-down-3-3-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cboe-data-shows-mixed-options-sentiment-in-sellas-life-sciences-with-shares-down-3-3-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","SLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101501712","title":"Movement Alert｜SELLAS Life Sciences Group Inc. Falls 8.63% in Regular Trading, All Arbitration Claims Dismissed","url":"https://stock-news.laohu8.com/highlight/detail?id=1101501712","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1101501712?lang=en_us&edition=fundamental","pubTime":"2026-07-28 22:19","pubTimestamp":1785248392,"startTime":"0","endTime":"0","summary":"On July 28, SELLAS Life Sciences Group Inc. fell 8.63% in regular trading, trading at $9.505/share, with turnover of $30.53 million.On the news front, 3D Medicines announced that the arbitration case...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654884708","title":"Moderately bullish activity in Sellas Life Sciences with shares down 11.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2654884708","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654884708?lang=en_us&edition=fundamental","pubTime":"2026-07-28 22:15","pubTimestamp":1785248140,"startTime":"0","endTime":"0","summary":"Moderately bullish activity in Sellas Life Sciences (SLS), with shares down $1.21 near $9.62. Options volume running well above average with 19k co...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/moderately-bullish-activity-in-sellas-life-sciences-with-shares-down-11-17-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/moderately-bullish-activity-in-sellas-life-sciences-with-shares-down-11-17-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","SLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654028744","title":"Sellas Life Sciences Group - Company to Pay About $1 Mln of 3D Medicines' Legal Fees - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2654028744","media":"THOMSON REUTERS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654028744?lang=en_us&edition=fundamental","pubTime":"2026-07-28 04:37","pubTimestamp":1785184622,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nFWN43T12D:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SLS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654028056","title":"Sellas Life Sciences Group Inc: 3D Medicines Will Continue Development & Commercialization of Galinpepimut-S in Greater China Territory","url":"https://stock-news.laohu8.com/highlight/detail?id=2654028056","media":"THOMSON REUTERS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654028056?lang=en_us&edition=fundamental","pubTime":"2026-07-28 04:37","pubTimestamp":1785184622,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nFWN43T12D:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SLS","01244","BK4139","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654202872","title":"Sellas Arbitration Claim Against 3D Medicines Dismissed, Owes $1 Million in Legal Fees","url":"https://stock-news.laohu8.com/highlight/detail?id=2654202872","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654202872?lang=en_us&edition=fundamental","pubTime":"2026-07-28 04:36","pubTimestamp":1785184600,"startTime":"0","endTime":"0","summary":"Sellas arbitration claim against 3D Medicines dismissed, owes $1 million in legal feesSellas lost a binding arbitration against 3D Medicines at the HKIAC, with the arbitrator dismissing its claims on ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nNDL3hNqMx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01244","BK1161","BK4139","SLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188783220","title":"Movement Alert｜SELLAS Life Sciences Group Inc. Falls 14.89% in Regular Trading, All Arbitration Claims Dismissed in Hong Kong Case","url":"https://stock-news.laohu8.com/highlight/detail?id=1188783220","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188783220?lang=en_us&edition=fundamental","pubTime":"2026-07-28 00:09","pubTimestamp":1785168593,"startTime":"0","endTime":"0","summary":"On July 28, SELLAS Life Sciences Group Inc. declined 14.89% in regular trading, trading at $9.9/share, with turnover of $46.72 million.On the news front, Sirnaomics announced that the arbitration...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165009697","title":"Movement Alert｜SELLAS Life Sciences Group Inc. Falls 8.35% in Regular Trading, Trading at $11.29","url":"https://stock-news.laohu8.com/highlight/detail?id=1165009697","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165009697?lang=en_us&edition=fundamental","pubTime":"2026-07-25 02:16","pubTimestamp":1784916995,"startTime":"0","endTime":"0","summary":"On July 25, SELLAS Life Sciences Group Inc. fell 8.35% in regular trading, trading at $11.29/share, with Turnover of $53.60 million.Within the Biotechnology sector where SELLAS Life Sciences Group...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110506485","title":"Movement Alert｜SELLAS Life Sciences Group Inc. Falls 8.06% in Regular Trading, Trading at $11.89","url":"https://stock-news.laohu8.com/highlight/detail?id=1110506485","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110506485?lang=en_us&edition=fundamental","pubTime":"2026-07-23 01:58","pubTimestamp":1784743101,"startTime":"0","endTime":"0","summary":"On July 23, SELLAS Life Sciences Group Inc. fell 8.06% in regular trading, trading at $11.89 USD/share, with Turnover of $44.64 million.Within the Biotechnology sector where SELLAS Life Sciences...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167508286","title":"Movement Alert｜SELLAS Life Sciences Falls 8.85% in Regular Trading, Trading at $12.075","url":"https://stock-news.laohu8.com/highlight/detail?id=1167508286","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167508286?lang=en_us&edition=fundamental","pubTime":"2026-07-20 21:55","pubTimestamp":1784555716,"startTime":"0","endTime":"0","summary":"On July 20, SELLAS Life Sciences fell 8.85% in regular trading, trading at $12.075 USD/share, with Turnover of $27.39 million.Within the Biotechnology sector where SELLAS Life Sciences belongs, the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652255493","title":"SELLAS Life Sciences Group (SLS) Stock Trades At A Premium On Book Value Despite A 7x Return","url":"https://stock-news.laohu8.com/highlight/detail?id=2652255493","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652255493?lang=en_us&edition=fundamental","pubTime":"2026-07-19 11:28","pubTimestamp":1784431730,"startTime":"0","endTime":"0","summary":"SELLAS Life Sciences Group stock has delivered a very large three year return while the broader valuation checks suggest the shares are expensive rather than a clear bargain.\n\nOver the past three years, SELLAS Life Sciences Group has returned about 7x, which puts extra attention on whether the current price already reflects much of the good news.\nExpectations for rapid revenue and earnings growth may support the current valuation, while the recently filed US$154.6m shelf registration...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-sls/sellas-life-sciences-group/news/sellas-life-sciences-group-sls-stock-trades-at-a-premium-on","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-sls/sellas-life-sciences-group/news/sellas-life-sciences-group-sls-stock-trades-at-a-premium-on","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["SLS","SLS.AU","BK4139","BK7104","TSPA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135961632","title":"Movement Alert｜SELLAS Life Sciences Rises 8.3% in Regular Trading, Trading at $13.04","url":"https://stock-news.laohu8.com/highlight/detail?id=1135961632","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135961632?lang=en_us&edition=fundamental","pubTime":"2026-07-17 22:36","pubTimestamp":1784298988,"startTime":"0","endTime":"0","summary":"On July 17, SELLAS Life Sciences rose 8.3% in regular trading, trading at $13.04 USD/share, with Turnover of $51.99 million.Within the Biotechnology sector where SELLAS Life Sciences belongs, the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652893672","title":"Sellas Life Sciences rises 10.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2652893672","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652893672?lang=en_us&edition=fundamental","pubTime":"2026-07-17 22:05","pubTimestamp":1784297157,"startTime":"0","endTime":"0","summary":"Sellas Life Sciences (SLS) is up 10.2%, or $1.20 to $12.95. Published first on TheFly – the ultimate source for real-time, market-moving breaking f...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/sellas-life-sciences-rises-10-2-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/sellas-life-sciences-rises-10-2-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SLS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173567320","title":"Movement Alert｜SELLAS Life Sciences Falls 8.6% in Regular Trading, Trading at $11.73","url":"https://stock-news.laohu8.com/highlight/detail?id=1173567320","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173567320?lang=en_us&edition=fundamental","pubTime":"2026-07-16 22:42","pubTimestamp":1784212965,"startTime":"0","endTime":"0","summary":"On July 16, SELLAS Life Sciences fell 8.6% in regular trading, trading at $11.73 USD/share, with Turnover of $36.72 million.Within the Biotechnology sector where SELLAS Life Sciences belongs, among...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651332449","title":"High Growth Tech Stocks To Watch In The US July 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2651332449","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651332449?lang=en_us&edition=fundamental","pubTime":"2026-07-16 19:08","pubTimestamp":1784200090,"startTime":"0","endTime":"0","summary":"The United States market has remained flat over the past week but has experienced a significant 21% rise over the last year, with earnings projected to grow by 18% annually. In this context, identifying high growth tech stocks involves looking for companies that demonstrate strong innovation and adaptability, positioning themselves well to capitalize on future opportunities in a dynamic economic environment.","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-annx/annexon/news/high-growth-tech-stocks-to-watch-in-the-us-july-2026","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-annx/annexon/news/high-growth-tech-stocks-to-watch-in-the-us-july-2026","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["APPX","LU0097036916.USD","ANNX","BK4539","LU0353189680.USD","LU2250418816.HKD","BK4585","LU0154236417.USD","BK4139","LU2360107168.USD","IE00B19Z9P08.USD","LU1852331112.SGD","SLS","BK4608","APP","IE00B894F039.SGD","LU2087625088.SGD","XDAT","LU2360106780.USD","CLOD","IE00BZ9MQY76.HKD","LU2063271972.USD","LU2290526834.HKD","IE00B19Z9Z06.USD","LU0056508442.USD","LU0353189763.USD","LU1861215975.USD","BK4023","LU1861220033.SGD","BK4588","BK4613"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650922763","title":"Galinpepimut-S REGAL Readout and Deal Chatter Might Change The Case For Investing In SELLAS (SLS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2650922763","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650922763?lang=en_us&edition=fundamental","pubTime":"2026-07-09 20:25","pubTimestamp":1783599920,"startTime":"0","endTime":"0","summary":"In recent comments, SELLAS Life Sciences Group CEO Angelos M. Stergiou addressed concerns about perceived delays in the pivotal Phase 3 REGAL trial for Galinpepimut-S in acute myeloid leukemia, clarifying that there is still no approved maintenance therapy for patients in a second complete remission and that 78 of the 80 required events for final analysis have now occurred.\nAt the same time, a small new position reported by CoreCap Advisors and updated change-of-control terms have fueled...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-sls/sellas-life-sciences-group/news/galinpepimut-s-regal-readout-and-deal-chatter-might-change-t","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-sls/sellas-life-sciences-group/news/galinpepimut-s-regal-readout-and-deal-chatter-might-change-t","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7104","SLS","SLS.AU","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649995531","title":"Sellas Life Sciences Group Inc : Maxim Group Raises Target Price to $30 from $10","url":"https://stock-news.laohu8.com/highlight/detail?id=2649995531","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649995531?lang=en_us&edition=fundamental","pubTime":"2026-07-08 20:12","pubTimestamp":1783512737,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260708:nFWN43A0VA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","SLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108491766","title":"Movement Alert｜SELLAS Life Sciences Group Rises 8.67% in Regular Trading, Trading at $14.47","url":"https://stock-news.laohu8.com/highlight/detail?id=1108491766","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108491766?lang=en_us&edition=fundamental","pubTime":"2026-07-02 22:06","pubTimestamp":1783001194,"startTime":"0","endTime":"0","summary":"On July 2, SELLAS Life Sciences Group rose 8.67% in regular trading, trading at $14.47 USD/share, with turnover of $31.87 million.Within the Biotechnology sector where SELLAS Life Sciences Group...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SLS"],"isVideo":false,"video":null,"gpt_icon":1}],"profile":{"websiteUrl":"http://www.sellaslifesciences.com","stockEarnings":[{"period":"1week","weight":0.1743},{"period":"1month","weight":-0.1492},{"period":"3month","weight":1.4057},{"period":"6month","weight":2.1796},{"period":"1year","weight":6.321},{"period":"ytd","weight":2.1459}],"compareEarnings":[{"period":"1week","weight":0.0553},{"period":"1month","weight":0.0246},{"period":"3month","weight":0.0522},{"period":"6month","weight":0.1146},{"period":"1year","weight":0.2258},{"period":"ytd","weight":0.1289}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"SELLAS Life Sciences Group, Inc., a late-stage clinical biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. The company's lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase 3 clinical trials for the treatment of acute myeloid leukemia; and in Phase 1/2 clinical trials for the treatment for ovarian cancer. It has a strategic collaboration with Merck & Co., Inc. to evaluate GPS as it is administered in combination with PD1 blocker pembrolizumab in a Phase 1/2 clinical trial enrolling patients in up to five cancer indications, including hematologic malignancies and solid tumors; and GenFleet Therapeutics (Shanghai), Inc. for the development and commercialization of GFH009, a highly selective small molecule CDK9 inhibitor, currently under Phase 1 clinical trials. The company is headquartered in New York, New York.","yearOnYearQuotes":[{"month":1,"riseRate":0.416667,"avgChangeRate":-0.030636},{"month":2,"riseRate":0.5,"avgChangeRate":-0.01322},{"month":3,"riseRate":0.25,"avgChangeRate":-0.060862},{"month":4,"riseRate":0.5,"avgChangeRate":0.097703},{"month":5,"riseRate":0.75,"avgChangeRate":0.182109},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.13341},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.057089},{"month":8,"riseRate":0.416667,"avgChangeRate":-0.038277},{"month":9,"riseRate":0.272727,"avgChangeRate":-0.031827},{"month":10,"riseRate":0.363636,"avgChangeRate":0.051142},{"month":11,"riseRate":0.25,"avgChangeRate":-0.061889},{"month":12,"riseRate":0.25,"avgChangeRate":0.046982}],"exchange":"NASDAQ","name":"SELLAS Life Sciences Group Inc.","nameEN":"SELLAS Life Sciences Group Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"SELLAS Life Sciences Group Inc.(SLS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest SELLAS Life Sciences Group Inc.(SLS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"SELLAS Life Sciences Group Inc.,SLS,SELLAS Life Sciences Group Inc.股票,SELLAS Life Sciences Group Inc.股票老虎,SELLAS Life Sciences Group Inc.股票老虎国际,SELLAS Life Sciences Group Inc.行情,SELLAS Life Sciences Group Inc.股票行情,SELLAS Life Sciences Group Inc.股价,SELLAS Life Sciences Group Inc.股市,SELLAS Life Sciences Group Inc.股票价格,SELLAS Life Sciences Group Inc.股票交易,SELLAS Life Sciences Group Inc.股票购买,SELLAS Life Sciences Group Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"SELLAS Life Sciences Group Inc.(SLS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest SELLAS Life Sciences Group Inc.(SLS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}